Skip to content

Renal Replacement Therapy in Neonates

Renal Replacement Therapy in Neonates : a Retrospective Monocentric Cohort Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05456659
Acronym
Neo-Renal
Enrollment
72
Registered
2022-07-13
Start date
2022-04-30
Completion date
2022-10-27
Last updated
2022-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Failure

Keywords

Neonatal, Dialysis, Extra-renal purification, Neonatal resuscitation

Brief summary

The circumstances for setting up dialysis in the neonatal period are multiple: congenital anomaly of the kidney and urinary tract (CAKUT), secondary acute renal failure whose etiologies are multiple (sepsis, hypovolemia, respiratory distress syndrome, neonatal asphyxia, Arterial or venous renal thrombosis, nephrotoxic drugs, etc.), metabolic diseases (mainly hyperammonemia and leucinosis) and post-operative management of heart disease: analysis of the characteristics of the patients in our study and comparison with existing epidemiological data in the literature. The decision to set up dialysis in a newborn whose recovery of renal function is uncertain or in a context of acute multi-visceral failure is not always obvious and must be discussed carefully. multidisciplinary in connection with neonatologists, resuscitators and nephrologists as well as families with the consideration of the future quality of life of the child.

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Days to 28 Days
Healthy volunteers
No

Inclusion criteria

* Minor under 28 days old * Having benefited from a renal purification technique in the pediatric intensive care unit of the University Hospital of Strasbourg * Holders of parental authority who do not object to the reuse of their child's data for scientific research purposes.

Exclusion criteria

\- Holders of parental authority who have expressed their opposition to the reuse of their child's data for scientific research purposes.

Design outcomes

Primary

MeasureTime frame
Description of clinical characteristics of patients, survival and technical modalities of dialysis in children undergoing neonatal dialysis at the Strasbourg University HospitalFiles analysed retrospectively from January 01, 2010 to December 31, 2021 will be examined

Countries

France

Contacts

Primary ContactAriane ZALOSZYC, MD
ariane.zaloszyc@chru-strasbourg.fr33 3 88 12 77 49
Backup ContactSaïd CHAYER, PhD, HDR
said.chayer@chru-strasbourg.fr

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026